PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
13-Aug-2020 Novo Nordisk resumes the phase 3 clinical trials investigating concizumab (anti-TFPI mAB) in haemophilia A and B with or without inhibitors Novo Nordisk
13-Aug-2020 Novartis appoints Marc Boutin as Global Head of Patient Engagement & Advocacy Novartis
13-Aug-2020 THREAD Accelerates Expansion to Advance Global Decentralized Clinical Trials THREAD
13-Aug-2020 Johnson & Johnson Named to Fast Company's 2020 Best Workplaces for Innovators List Johnson & Johnson
13-Aug-2020 New England Journal of Medicine Publishes Positive Phase 3 Data of Venetoclax Combination in Acute Myeloid Leukemia (AML) Patients Abbvie
13-Aug-2020 Moderna Announces Supply Agreement with U.S. Government for Initial 100 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273) Moderna
13-Aug-2020 FDA approves Roche’s Evrysdi (risdiplam) for treatment of spinal muscular atrophy (SMA) in adults and children 2 months and older Roche
13-Aug-2020 Novavax Reports Second Quarter 2020 Financial and Operational Results Novavax
13-Aug-2020 Epigenomics AG presents operational highlights and reports financial results for first six months of 2020 Epigenomics AG
13-Aug-2020 Douglas safely navigates through corona crisis - record growth in e-commerce Douglas GmbH
13-Aug-2020 Eckert & Ziegler Records Solid Half-Year Results. Growth Trend for Radiopharmaceuticals Remains Intact. Eckert & Ziegler Strahlen- und Medizintechnik AG
13-Aug-2020 4basebio AG: 4basebio AG reports first six months of 2020 financial results 4basebio AG
13-Aug-2020 Biotest AG: Biotest increases sales in the first half of 2020 by over 20% to € 234.8 million Biotest AG
13-Aug-2020 STRATEC WITH SIGNIFICANT SALES GROWTH AND INCREASED PROFITABILITY IN THE FIRST HALF OF 2020 STRATEC SE
13-Aug-2020 CanSinoBIO's Successful Listing on STAR Market Makes it the Initial Dual Listing Vaccine Company CanSino Biologics Inc.
13-Aug-2020 CanSinoBIO's Successful Listing on STAR Market Makes it the Initial Dual Listing Vaccine Company CanSino Biologics Inc.
12-Aug-2020 NS Pharma's VILTEPSO(TM) (viltolarsen) injection Now FDA-Approved in the U.S. for the Treatment of Duchenne Muscular Dystrophy in Patients Amenable to Exon 53 Skipping Therapy NS Pharma
12-Aug-2020 Pharming announces enrollment of first patient in multinational clinical trial for the treatment of COVID-19 with RUCONEST® Pharming Group N.V.
12-Aug-2020 Rapid Nutrition PLC: Rapid Nutrition Welcomed Into Entrepreneurs Programme for Business Innovation Rapid Nutrition PLC
12-Aug-2020 Bayer to acquire UK-based biotech KaNDy Therapeutics Ltd. KaNDy Therapeutics Ltd